MMCM
TDOC icon

Murphy & Mullick Capital Management’s Teladoc Health TDOC Stock Holding History

Murphy & Mullick Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-330
Closed -$2.88K – 834
2025
Q3 		$2.88K Hold
330
– – ﹤0.01% 575
2025
Q2 		$2.87K Sell
330
-1,000
-75% -$7.25K ﹤0.01% 561
2025
Q1 		$10.6K Hold
1,330
– – 0.01% 435
2024
Q4 		$12.1K Buy
+1,330
New +$12.8K 0.01% 412

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Murphy & Mullick Capital Management's TDOC Position: Q4 2025 in Review

Murphy & Mullick Capital Management sold out of Teladoc Health (TDOC) in Q4 2025, closing a stake of 330 shares — an estimated $2.88K sold.

Murphy & Mullick Capital Management first reported a position in TDOC in Q4 2024 and held it in 4 quarters. The position peaked at $12.1K in Q4 2024. 344 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

  • Murphy & Mullick Capital Management reported no remaining Teladoc Health position as of Q4 2025 after selling out during the quarter.
  • Murphy & Mullick Capital Management sold 330 Teladoc Health shares in Q4 2025, an estimated $2.88K.
  • Murphy & Mullick Capital Management first reported a position in Teladoc Health in Q4 2024 and held it in 4 quarters.
  • Murphy & Mullick Capital Management's Teladoc Health position peaked at $12.1K in Q4 2024.
  • 344 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on Murphy & Mullick Capital Management's 13F filing for Q4 2025, filed 10 Feb 2026.